QA: Virios Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001818844_2023_Virios_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001818844, Virios Therapeutics Inc.

  xvar xval
0 AssetsCurrent 8,369,756
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 1,043,262
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,245,681
9 ResearchAndDevelopmentExpense 8,069,628
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 67,475
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 8,369,756
1 Liabilities 1,043,262
2 Expenses 12,315,309
3 Revenues 0
4 StockholdersEquity 7,326,494
5 NetIncome -12,247,834
6 ComprehensiveNetIncome -12,247,834
7 BaseVar 10,897,901
8 EconomicCapitalRatio 0.0752

Edgar->Model Mapping

Feature Distribution

Change over Time